Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines.

ABSTRACT:

Background

Cancer screening should be recommended only when the balance between benefits and harms is favorable. This review evaluated how U.S. cancer screening guidelines reported harms, within and across organ-specific processes to screen for cancer.

Objective

To describe current reporting practices and identify opportunities for improvement.

Design

Review of guidelines.

Setting

United States.

Patients

Patients eligible for screening for breast, cervical, colorectal, lung, or prostate cancer according to U.S. guidelines.

Measurements

Information was abstracted on reporting of patient-level harms associated with screening, diagnostic follow-up, and treatment. The authors classified harms reporting as not mentioned, conceptual, qualitative, or qua

SUBMITTER: Kamineni A 

PROVIDER: S-EPMC9903969 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature